EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Model‐Based Prediction of Clinically Relevant Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation

Katharina M Götz iD, Amin T Turki, Katharina Och, Dominik Selzer iD, Christian Brossette, Norbert Graf iD, Jochen Rauch, Stefan Theobald, Yvonne Braun, Kerstin Rohm iD, Gabriele Weiler, Simeon Rüdesheim iD und 12 weitere

Clinical Pharmacology & Therapeutics · 2025

DOI: 10.1002/cpt.3580 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2025. Verfasst von Katharina M Götz und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Saarland University, Saarbrücken, Germany. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Thrombocytopenia, Models, Biological. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platelet reconstitution after allogeneic hematopoietic cell transplantation (allo‐HCT) is heterogeneous and influenced by various patient‐ and transplantation‐related factors, associated with poor prognoses for poor graft function (PGF) and isolated thrombocytopenia. Tailored interventions could improve the outcome of patients with PGF and post‐HCT thrombocytopenia. To provide individual predictions of 180‐day platelet counts from early phase data, we developed a model of long‐term platelet reconstitution after allo‐HCT. A large cohort ( n = 1949) of adult patients undergoing their first allo‐HCT was included. Real‐world data from 1,048 retrospective patients were used for non‐linear mixed‐effects model development. Bayesian forecasting was used to predict platelet–time profiles for 518 retrospective and 383 prospective patients during internal and external model validation, respectively. Thrombocytopenia was defined as mean platelet count < 75 × 10 9 /L, derived from the last 12 platelet measurements within the first 180 days post‐HCT. Thrombocytopenia affected 37% of all patients and was associated with significantly reduced overall survival ( P ‐value < 0.0001). On days +7, +14, +21, and +28, the developed model achieved areas under the receiver‐operating characteristic of ≥ 0.68, ≥ 0.75, ≥ 0.78, and 0.81 for the prediction of post‐HCT thrombocytopenia, respectively, with anti‐thymocyte globulin, donor relation, and total protein measurements representing prognostic markers for post‐HCT platelet kinetics. A publicly accessible web‐based demonstrator of the model was established ( https://hsct.precisiondosing.de ). In summary, the developed model predicts individual platelet counts from day +28 post‐HCT adequately, utilizing internal and external datasets. The web‐based demonstrator provides a basis to implement model‐based predictions in clinical practice and to confirm these findings in future clinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationThrombocytopeniaModels, BiologicalHumansMaleFemaleMiddle AgedAdultRetrospective StudiesPlatelet CountBayes TheoremTransplantation, HomologousAgedYoung AdultProspective StudiesPredictive Value of Tests

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Saarland University, Saarbrücken, Germany.
  • Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.
  • Department of Hematology and Oncology, Marienhospital University Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Department of Pediatric Oncology and Hematology, Saarland University, Homburg, Germany.
  • Department of Biomedical Data & Bioethics, Fraunhofer Institute for Biomedical Engineering (IBMT), Sulzbach, Germany.
  • Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.

ORCID-Profile: Katharina M Götz, Dominik Selzer, Norbert Graf, Kerstin Rohm, Simeon Rüdesheim, Matthias Schwab, Stephan Kiefer, Thorsten Lehr

Zitieren

APA

Götz, K. M., Turki, A. T., Och, K., Selzer, D., Brossette, C., Graf, N., Rauch, J., Theobald, S., Braun, Y., Rohm, K., Weiler, G., Rüdesheim, S., Schwab, M., Eisenberg, L., Pfeifer, N., Kiefer, S., Schwarz, U., Riede, C., Smola, S., …, & Lehr, T. (2025). Model‐Based Prediction of Clinically Relevant Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3580

Vancouver

Götz KM, Turki AT, Och K, Selzer D, Brossette C, Graf N, et al. Model‐Based Prediction of Clinically Relevant Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation. Clinical Pharmacology & Therapeutics. 2025. doi:10.1002/cpt.3580

BibTeX
@article{Gtz2025,
  author = {Götz, Katharina M and Turki, Amin T and Och, Katharina and Selzer, Dominik and Brossette, Christian and Graf, Norbert and Rauch, Jochen and Theobald, Stefan and Braun, Yvonne and Rohm, Kerstin and Weiler, Gabriele and Rüdesheim, Simeon and Schwab, Matthias and Eisenberg, Lisa and Pfeifer, Nico and Kiefer, Stephan and Schwarz, Ulf and Riede, Claudia and Smola, Sigrun and Beelen, Dietrich W and Kaddu-Mulindwa, Dominic and Rissland, Jürgen and Bittenbring, Jörg and Lehr, Thorsten},
  title = {Model‐Based Prediction of Clinically Relevant Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1002/cpt.3580}
}
Kostenlos starten →